T1	Participants 66 83	solar lentigines:
T2	Participants 550 655	This prospective, randomized, controlled, investigator-blinded, single-centre study enrolled 50 patients.
T3	Participants 656 676	Twenty-five patients
T4	Participants 759 770	25 received
